Advertisement
Screener

ISRAEL ACQUISITIONS CORP (ISRL) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

ISRAEL ACQUISITIONS CORP Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

ISRAEL ACQUISITIONS CORP (ISRL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 14.38 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14

  • ISRAEL ACQUISITIONS CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 14.38M shares, a 0.00% change year-over-year.
  • ISRAEL ACQUISITIONS CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 14.38M shares, a 0.00% change year-over-year.
  • ISRAEL ACQUISITIONS CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 14.38M shares, a 0.00% change year-over-year.
  • ISRAEL ACQUISITIONS CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 14.38M shares.
  • ISRAEL ACQUISITIONS CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 14.38M shares, a 0.00% change from fiscal 2024.
  • ISRAEL ACQUISITIONS CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 14.38M shares, a 0.00% change from fiscal 2023.
  • ISRAEL ACQUISITIONS CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 14.38M shares.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month
2026-06-3014.38M shares
10-Q · filed 2026-08-14
2026-03-3114.38M shares
10-Q · filed 2026-05-15
2025-12-3114.38M shares
10-K · filed 2026-03-31
2025-09-3014.38M shares
10-Q · filed 2025-11-14
2025-06-3014.38M shares
10-Q · filed 2025-08-13
2025-03-3114.38M shares
10-Q · filed 2025-05-14
2024-12-3114.38M shares
10-K · filed 2025-03-31
2024-09-3014.38M shares
10-Q · filed 2024-11-15
2024-06-3014.38M shares
10-Q · filed 2024-08-14
2024-03-3114.38M shares
10-Q · filed 2024-05-15
2023-12-3114.38M shares
10-K · filed 2024-03-28
2023-09-3014.38M shares
10-Q · filed 2023-11-13
2023-06-3014.38M shares
10-Q · filed 2023-08-14
2023-03-3114.38M shares
10-Q · filed 2023-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aimei Health Technology Co., Ltd. (AFJK)United States$0.038B
CO2 Energy Transition Corp. (NOEM)United States$0.040B
Innventure, Inc. (INV)United States$0.068B-2.99
Origin Investment Corp I (ORIQ)$0.090B13.93
XFLH Capital Corp (XFLH)United States$0.139B
Aldel Financial II Inc. (ALDF)United States$0.323B